[IPO Weekly Report] 4th Week of July, 3 Companies Including Nex-I File for Listing… 4 Approvals

In the 4th week of July 2026 (July 20 to July 24), a total of 3 companies filed for preliminary listing eligibility reviews, and 4 companies received approval in the IPO market. Additionally, 1 company conducted demand forecasting, 1 company proceeded with public subscriptions, and 2 companies entered the stock market, continuing an active schedule.

Listing Requests

• Nex-I: A bio venture company that researches and develops next-generation anti-cancer immunotherapy drugs targeting factors that induce rejection in immunotherapy treatments. Lead Manager: Korea Investment & Securities Co., Ltd., Filing Date: 2026-07-21

• Adel: A bio company developing antibody therapeutics and diagnostic technologies targeting the Tau protein, which is a causative agent of degenerative brain diseases such as Alzheimer's disease. Lead Managers: Samsung Securities Co., Ltd. and Mirae Asset Securities Co., Ltd., Filing Date: 2026-07-21

• Xenon: A company that professionally produces and supplies high-purity specialty gases and eco-friendly air pollution reduction equipment used in semiconductor and display manufacturing processes. Lead Manager: Samsung Securities Co., Ltd., Filing Date: 2026-07-23

Approvals

• Global Technology: A specialized semiconductor company providing high-performance semiconductor IP and system semiconductor design solutions for data centers and servers based on ultra-high-speed interface technology. Lead Manager: Korea Investment & Securities, Filed on April 13, Approved on July 19

• Duksan Nepcores (formerly Nepcores): An advanced navigation system specialized company possessing technologies for Global Positioning Systems (GPS), defense industry navigation solutions, and aerospace receivers. Lead Manager: Daishin Securities, Filed on November 11, Approved on July 19

• DTS (formerly Dongyang TS): A plant equipment company that manufactures and constructs high-efficiency heat exchangers and mechanical equipment applied to large-scale industrial plants such as power plants and petrochemical factories. Lead Manager: Daishin Securities, Filed on September 18, Approved on July 19

• NH SPAC No. 34: Lead Manager: NH Investment & Securities, Filed on May 29, Approved on July 21

Demand Forecasting

• Dealicious: A fashion startup that operates the B2B platform 'Sinsang Market' connecting the Dongdaemun fashion wholesale and retail market and provides logistics fulfillment services. Conducting demand forecasting for institutional investors

Public Subscription

• Ingenia Therapeutics: Lead Manager: Samsung Securities, Offering Price Undetermined

Listings

• HL Genomics: A specialized genomic analysis company providing early diagnosis and customized healthcare solutions for cancer and rare diseases using next-generation sequencing (NGS)-based genetic testing technology. Lead Managers: KB Securities Co., Ltd. and IBK Investment & Securities Co., Ltd.

• Songwoo Infotech: A company that provides Intelligent Transport Systems (ITS) and smart traffic control solutions based on deep learning-based video analysis source technology. Lead Manager: IBK Investment & Securities Co., Ltd.

Next Week's Schedule

• Nearthlab: A company that provides safety inspection solutions for large facilities such as wind turbines and bridges by utilizing autonomous drone technology and AI-based infrastructure inspection software. Demand forecasting scheduled

• Kido Industrial: An export-oriented company that professionally develops and manufactures (OEM/ODM) high-performance winter and protective clothing for world-renowned outdoor and motorcycle brands. Demand forecasting scheduled

• Ingenia Therapeutics: A Korean-American bio company developing new drugs for intractable vascular diseases such as diabetic macular edema and wet macular degeneration based on a protein engineering technology platform (Tie2 activation). Lead Manager: Samsung Securities, Payment scheduled